Cannabis psychosis and acute schizophrenia. a case-control study from India.
D Basu, Anita S Malhotra, Anumeha Bhagat, V K Varma
European Addiction Research June 1, 1999 DOI: 10.1159/000018968 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case-control study using retrospective chart review Peer reviewed |
|---|---|
| Sample size | 40 |
| Population | Patients with cannabis psychosis or acute schizophrenic episode in India |
| Topics | Cannabis |
| Key findings | Cannabis psychosis may be nosologically distinct from schizophrenia, with shorter duration, reactive affect, and relapse always preceded by cannabis use. |
Abstract
Twenty cases of cannabis psychosis were compared with a control group of 20 patients with 'acute schizophrenic episode' on a number of demographic, clinical, illness-related and outcome variables in a case-control study design using a retrospective chart review. The two groups were comparable on demographic, past and family histories of mental illness, premorbid personality, psychomotor activity, Schneiderian first-rank symptoms and mild cognitive deficits. The cases, in contrast to the control group, had a psychosis of shorter duration characterized by reactive and congruent affect, relative absence of schizophrenic formal thought disorder and a predominantly polymorphic clinical picture. Relapse was always preceded by cannabis use. This study suggests that, in spite of certain overlaps, 'cannabis psychosis' may still be considered nosologically distinct from schizophrenia in India. The implication of the study is that the role of cannabis in any acute psychosis should be investigated carefully so as to prevent an overdiagnosis of schizophrenia.
Comparable studies
Other observational and cohort studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population | 2009 | Case-control study | n = 454 |
| Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population | 2013 | Observational study | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline | 2011 | Observational cohort | n = 1,923 |
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... | 2005 | Observational cohort | n = 535 |
Citations in the library
Cited by 20
- Gone to Pot – A Review of the Association between Cannabis and Psychosis Frontiers in Psychiatry May 22, 2014
- Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases The British Journal of Psychiatry November 30, 2005
- Familial Predisposition for Psychiatric Disorder Archives of General Psychiatry November 3, 2008
- A review of Indian research on co-occurring cannabis use disorders & psychiatric disorders The Indian journal of medical research August 1, 2017
- Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report Journal of Medical Case Reports September 11, 2015
and 15 more in the library
Cites 5
- Psychiatric effects of cannabis use Acta Psychiatrica Scandinavica September 1, 1985
- Cannabis and psychotic illness. The British Journal of Psychiatry November 1, 1992
- Cannabis psychosis following bhang ingestion. British Journal of Addiction September 1, 1991
- Cannabis-associated psychosis with hypomanic features. The Lancet December 18, 1982
- Cannabis psychosis and paranoid schizophrenia. Archives of General Psychiatry March 1, 1976